BiomX Inc
For the period ended Jun 30, 2024. Filed Aug 14, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 14, 2024
HLSQ$0.07-37.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets (unaudited)
CONDENSED CONSOLIDATED BALANCE SHEETS
| As of | ||
|---|---|---|
| June 30, 2024 | December 31, 2023 | |
| ASSETS | ||
| Current assets | ||
| Cash and cash equivalents | 31,611 | 14,907 |
| Restricted cash | 1,103 | 957 |
| Other current assets | 2,367 | 1,768 |
| Total current assets | 35,081 | 17,632 |
| Non-current assets | ||
| Other assets | 378 | - |
| Operating lease right-of-use assets | 10,423 | 3,495 |
| Property and equipment, net | 6,949 | 3,902 |
| In-process Research and development (“IPR&D”) assets and Goodwill | 15,788 | - |
| Total non-current assets | 33,538 | 7,397 |
| 68,619 | 25,029 | |
CONDENSED CONSOLIDATED BALANCE SHEETS
| As of | ||
|---|---|---|
| June 30, 2024 | December 31, 2023 | |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities | ||
| Trade accounts payable | 3,240 | 1,381 |
| Current portion of lease liabilities | 1,047 | 666 |
| Other accounts payable | 3,018 | 3,344 |
| Current portion of long-term debt | - | 5,785 |
| Total current liabilities | 7,305 | 11,176 |
| Non-current liabilities | ||
| Contract liability | - | 1,976 |
| Long-term debt, net of current portion | - | 5,402 |
| Operating lease liabilities, net of current portion | 8,849 | 3,239 |
| Other liabilities | 153 | 155 |
| Private Placement Warrants | 24,887 | - |
| Total non-current liabilities | 33,889 | 10,772 |
| Commitments and Contingencies (Note 7) | ||
| Stockholders’ equity | ||
| Preferred Stock, $0.0001 par value; Authorized – 1,000,000 shares as of June 30, 2024 and December 31, 2023. Issued and outstanding- 256,887 as of June 30, 2024. No shares issued and outstanding as of December 31, 2023. | 32,420 | - |
| Common Stock, $0.0001 par value; Authorized – 120,000,000 shares as of June 30, 2024 and December 31, 2023. Issued and outstanding -69,806,447 shares as of June 30, 2024 and 45,979,930 shares as of December 31, 2023. | 5 | 3 |
| Additional paid in capital | 170,826 | 166,048 |
| Accumulated deficit | (175,826) | (162,970) |
| Total stockholders’ equity | 27,425 | 3,081 |
| 68,619 | 25,029 | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.